Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
48.42
-1.30 (-2.61%)
Jul 9, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Hold Maintains $62.00 | Hold | Maintains | $62.00 | +28.05% | May 28, 2026 |
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $110.96 | Buy | Maintains | $110.96 | +129.16% | Apr 28, 2026 |
Unknown Analyst Orient Securities No rating | Orient Securities | Buy Maintains $81.01 → $103.06 | Buy | Maintains | $81.01 → $103.06 | +112.85% | Apr 21, 2026 |
Unknown Analyst Huafu Securities No rating | Huafu Securities | Buy Maintains $101.90 → $140.75 | Buy | Maintains | $101.90 → $140.75 | +190.69% | Apr 15, 2026 |
Andy Wang CMB International Securities No rating | CMB International Securities | Buy Maintains $100.50 | Buy | Maintains | $100.50 | +107.56% | Mar 31, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $108.00 | Buy | Maintains | $108.00 | +123.05% | Mar 30, 2026 |